News
12-03-2008, 03:20 AM
Mylan Inc. has announced that it and its subsidiary, Mylan Pharmaceuticals Inc., have entered into a settlement agreement with Novartis Pharmaceuticals Corp., Novartis Corp. and Novartis International AG related to Letrozole Tablets, the generic version of Novartis' Femara.
More... (http://www.news-medical.net/?id=43685)
More... (http://www.news-medical.net/?id=43685)